Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety and clinical efficacy of adalimumab in
active psoriatic arthritis (PsA) subjects when adalimumab is added to insufficient standard
therapy including patients that have failed other TNF therapies